...
机译:T淋巴细胞表达临床嵌合抗原受体的T淋巴细胞靶向和抑制HER3阳性乳腺癌
State Key Laboratory of Cancer Biology Department of Immunology Fourth Military Medical University;
Department of Biochemistry and Molecular Biology Fourth Military Medical University;
State Key Laboratory of Cancer Biology Department of Immunology Fourth Military Medical University;
State Key Laboratory of Cancer Biology Department of Immunology Fourth Military Medical University;
Department of Biochemistry and Molecular Biology Fourth Military Medical University;
State Key Laboratory of Cancer Biology Department of Immunology Fourth Military Medical University;
Department of Biochemistry and Molecular Biology Fourth Military Medical University;
Chimeric antigen receptor; Heregulin; HER3; HER2; Breast cancer;
机译:T淋巴细胞表达临床嵌合抗原受体的T淋巴细胞靶向和抑制HER3阳性乳腺癌
机译:表达L1-CAM受限制表位的多种实体瘤可通过嵌合抗原受体重定向的T淋巴细胞靶向
机译:经过改造的T淋巴细胞可表达CD16嵌合抗原受体,从而重定向T细胞针对免疫球蛋白G调理靶细胞的免疫反应
机译:用慢病毒载体修饰T淋巴细胞以表达抗CD19嵌合抗原受体(CAR)
机译:嵌合抗原受体修饰的人T淋巴细胞的产生,可有效和消灭小鼠中的人类癌症。
机译:通过表达特定嵌合抗原受体的自然杀伤细胞靶向表皮生长因子过度表达三重阴性乳腺癌
机译:在霍奇金肿瘤模型中,共表达CCR4和靶向CD30的嵌合抗原受体的T淋巴细胞具有改善的归巢和抗肿瘤活性